Equities Analysts Offer Predictions for ACHC FY2024 Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Zacks Research decreased their FY2024 earnings per share (EPS) estimates for Acadia Healthcare in a report released on Wednesday, November 13th. Zacks Research analyst Z. Masood now forecasts that the company will earn $3.37 per share for the year, down from their previous forecast of $3.46. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.71 EPS, Q1 2025 earnings at $0.76 EPS, Q2 2025 earnings at $0.94 EPS, Q1 2026 earnings at $0.88 EPS, Q2 2026 earnings at $0.99 EPS, Q3 2026 earnings at $1.07 EPS and FY2026 earnings at $3.99 EPS.

Other research analysts have also issued reports about the company. Royal Bank of Canada reissued an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a report on Friday, September 20th. StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Thursday. Barclays cut their target price on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research report on Monday, September 30th. KeyCorp assumed coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 1st. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $86.67.

Acadia Healthcare Stock Performance

Acadia Healthcare stock opened at $37.82 on Monday. The firm’s fifty day moving average price is $58.05 and its 200 day moving average price is $65.55. Acadia Healthcare has a 12-month low of $37.78 and a 12-month high of $87.77. The company has a market capitalization of $3.51 billion, a price-to-earnings ratio of 12.40, a price-to-earnings-growth ratio of 1.68 and a beta of 1.33. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.91 EPS.

Hedge Funds Weigh In On Acadia Healthcare

A number of hedge funds have recently made changes to their positions in ACHC. GAMMA Investing LLC lifted its holdings in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares in the last quarter. Blue Trust Inc. increased its position in shares of Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after purchasing an additional 248 shares during the last quarter. Commonwealth Equity Services LLC lifted its stake in Acadia Healthcare by 3.5% in the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock valued at $513,000 after purchasing an additional 257 shares during the last quarter. Atria Investments Inc raised its stake in shares of Acadia Healthcare by 4.7% in the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after buying an additional 308 shares during the period. Finally, KBC Group NV lifted its position in shares of Acadia Healthcare by 14.4% during the 3rd quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after buying an additional 338 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.